EDIT:NASDAQ
Editas Medicine Inc
1,82 $
arrow_downward
-0,27%(-0,0050) 1D
18 նոյ, 14:19:11 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,86 $
High
1,94 $
Low
1,81 $
Mkt. cap
280,13 մլն
Avg. vol.
2,39 մլն
Volume
1,28 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,86 $
High
1,94 $
Low
1,81 $
Mkt. cap
280,13 մլն
Avg. vol.
2,39 մլն
Volume
1,28 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
1 ժամ առաջ
S&P 500 Unusual Volume Movers: Nov. 18, 2026
The Motley Fool
·
1 ժամ առաջ
If You'd Invested $1,000 in an S&P 500 ETF Ahead of the Dot-Com Bubble, Here's What You'd Have Today
ChartMill
·
1 ժամ առաջ
S&P 500 Top Movers: Gainers and Losers in the Nov. 18, 2026 US Session
StoneX
·
7 ժամ առաջ
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc